Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126672481 | 12667248 | 1 | I | 20160811 | 0 | 20160818 | 20160818 | DIR | 22.00 | YR | F | N | 99.00000 | LBS | 20160816 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126672481 | 12667248 | 1 | PS | SUBOXONE | BUPRENORPHINE HYDROCHLORIDENALOXONE HYDROCHLORIDE | 1 | Sublingual | 8-2MG 1 FILMS BID SL | Y | D | 0 | 1 | DF | BID | |||||
| 126672481 | 12667248 | 3 | C | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 1 | 0 | ||||||||||||
| 126672481 | 12667248 | 4 | C | MELATONIN | MELATONIN | 1 | 0 | ||||||||||||
| 126672481 | 12667248 | 6 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | 0 | ||||||||||||
| 126672481 | 12667248 | 8 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126672481 | 12667248 | 1 | Drug dependence |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126672481 | 12667248 | Headache | |
| 126672481 | 12667248 | Oropharyngeal pain | |
| 126672481 | 12667248 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126672481 | 12667248 | 1 | 20160712 | 20160815 | 0 |